ChronoScale Corporation Common Stock (CHRN) Stock Price, News & Analysis

Company Overview

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Key Stats

• Today's Range: $18.21 to $19.46
• 50-Day Range: $17.66 to $24.45
• 52-Week Range: $3.50 to $30.00
• Volume: 108,216 shs
• Average Volume: 227,786 shs
• Market Capitalization: $2.71 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $19.00
• Consensus Rating: Hold

ChronoScale Corporation Common Stock Stock Analysis - MarketRank™

ChronoScale Corporation Common Stock scored higher than 5% of companies evaluated by MarketBeat, and ranked 580th out of 598 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.6 / 5
• Analyst Rating: Hold

Consensus Rating

ChronoScale Corporation Common Stock has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.

Upside/Downside

The consensus price target for ChronoScale Corporation Common Stock is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

ChronoScale Corporation Common Stock has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of ChronoScale Corporation Common Stock is -3.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of ChronoScale Corporation Common Stock is -3.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

ChronoScale Corporation Common Stock has a P/B Ratio of 5.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

0.52% of the float of ChronoScale Corporation Common Stock has been sold short.

Short Interest Ratio / Days to Cover

ChronoScale Corporation Common Stock has a short interest ratio ("days to cover") of 5.18.

Change versus previous month

Short interest in ChronoScale Corporation Common Stock has recently increased by 9.80%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

ChronoScale Corporation Common Stock does not currently pay a dividend.

Dividend Growth

ChronoScale Corporation Common Stock does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for ChronoScale Corporation Common Stock this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, ChronoScale Corporation Common Stock insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.35% of the stock of ChronoScale Corporation Common Stock is held by insiders.

Percentage Held by Institutions

6.42% of the stock of ChronoScale Corporation Common Stock is held by institutions.

Company Calendar

• Last Earnings: 8/19/2026
• Today: 10/09/2026
• AGM 2026: 11/06/2026
• Fiscal Year End: 5/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Technology
• Industry: IT Services
• Sub-Industry: Internet Services & Infrastructure
• Current Symbol: NASDAQ:CHRN
• Previous Symbol: NASDAQ:EKSO
• CIK: 1549084
• Web: www.eksobionics.com
• Phone: 510-984-1761
• Fax: 510-927-2647
• Employees: 60
• Year Founded: 2005

Price Target and Rating

• Average Price Target for ChronoScale Corporation Common Stock: $19.00
• High Price Target: $32.00
• Low Price Target: $6.00
• Potential Upside/Downside: +2.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($5.38)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$11.69 million
• Net Margins: -135.66%
• Pretax Margin: -135.66%
• Return on Equity: -197.81%
• Return on Assets: -74.17%

Debt

• Debt-to-Equity Ratio: 0.06
• Current Ratio: 0.51
• Quick Ratio: 0.51

Sales & Book Value

• Annual Sales: $71.60 million
• Price / Sales: 37.81
• Cash Flow: $0.31 per share
• Price / Cash Flow: 59.02
• Book Value: $3.44 per share
• Price / Book: 5.40

Miscellaneous

• Outstanding Shares: 145,637,000
• Free Float: 145,127,000
• Market Cap: $2.71 billion
• Optionable: No Data
• Beta: 0.98